NCT01603316 2026-03-12
Food: A Three-Arm Study Examining Food Insecurity Interventions
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Clinical Trials
50 trialsNCT00525720 2026-03-09
Brachytherapy for Prostatic Carcinoma Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06984861 2026-03-09
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT03028337 2026-03-05
Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT05681039 2026-03-02
Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT03568188 2026-02-24
FOCALE
Hospices Civils de Lyon
Phase 2 Completed
NCT03006848 2026-02-23
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01949662 2026-02-13
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT00618553 2026-01-12
Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06728579 2025-12-22
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
NCT05541016 2025-11-04
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mayo Clinic
Phase 2 Recruiting
NCT04401267 2025-11-03
Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01512589 2025-10-10
Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04497961 2025-09-11
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04837820 2025-04-23
The Effect of Acupuncture on Cancer-Related Cognitive Difficulties
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02124421 2024-11-19
CRS/HIPEC
Mercy Medical Center
Phase 2 Active not recruiting
NCT02280356 2024-03-04
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01854554 2024-01-02
Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01751438 2023-04-27
Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02055963 2022-10-20
Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01793051 2021-11-24
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01392183 2021-09-20
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02514252 2021-05-18
Sublingual Fentanyl for the Management of Breakthrough Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03628144 2020-09-10
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT02730884 2020-08-07
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01636934 2020-07-17
Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02949947 2020-04-06
Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01906008 2020-03-17
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01693523 2020-03-09
Minocycline Study in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02060370 2020-02-27
Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01900730 2020-02-25
Study of Valproic Acid (VPA) vs Placebo to Shorten Time of Indwelling Pleural Catheter
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00651937 2020-01-14
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02267278 2019-06-12
Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03128281 2019-05-30
Pneumoperitoneum Management With Low vs. Higher Pressure
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02410551 2018-10-30
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01746043 2018-06-06
A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01782976 2018-01-19
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02225496 2017-12-15
Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01603303 2017-08-18
Preventing Sexual Dysfunction With Aromatase Inhibitors
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02360059 2017-08-17
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00429507 2015-11-24
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02420587 2015-04-20
AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00867477 2014-08-28
PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01518140 2013-08-13
BiPAP-Vapotherm RCT
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00969085 2012-09-07
Trial of Curcumin in Cutaneous T-cell Lymphoma Patients
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT00353145 2012-08-02
Gemox as First and Second Line Therapy in Unknown Primary Cancer
M.D. Anderson Cancer Center
Phase 2 Completed